A methodological framework for drug development in rare diseases.
Nony P, Kurbatova P, Bajard A, Malik S, Castellan C, Chabaud S, Volpert V, Eymard N, Kassai B, Cornu C; CRESim; Epi-CRESim.
Nony P, et al. Among authors: volpert v.
Orphanet J Rare Dis. 2014 Nov 18;9:164. doi: 10.1186/s13023-014-0164-y.
Orphanet J Rare Dis. 2014.
PMID: 25774598
Free PMC article.